Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass

ClinicalTrials.gov ID: NCT00316212

Public ClinicalTrials.gov record NCT00316212. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 2:20 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to identify a dose or doses of INS50589 intravenous infusion that are well-tolerated and which reduce postoperative bleeding and blood product transfusion.

Study identification

NCT ID
NCT00316212
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2006 (Type not available)
Primary completion
Aug 2006 (Actual)
Completion
Not listed
Last update posted
Nov 18, 2016

Started 2006

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Baptist Medical Center Princeton Birmingham Alabama 35211 —
Cardiology, P.C. Birmingham Alabama 35211 —
Sharp Memorial Hospital San Diego California 92123 —
Memorial Medical Center Springfield Illinois 62702 —
St. John's Hospital Springfield Illinois 62769 —
Southern Illinois University School of Medicine Springfield Illinois 62794-9638 —
Lutheran Hospital of Indiana Fort Wayne Indiana 46804 —
Veterans Affairs Medical Center Lexington Kentucky 40506 —
University of Kentucky, Chandler Medical Center Lexington Kentucky 40536 —
St. Mary's of Michigan Saginaw Michigan 48601 —
Covenant Medical Center Saginaw Michigan 48602 —
Viahealth Rochester General Hospital Rochester New York 14621 —
Duke University Medical Center Durham North Carolina 27710 —
The Brody School of Medicine, East Carolina University Greenville North Carolina 27834 —
Cardiac, Vascular, & Thoracic Surgeons, Inc. Cincinnati Ohio 45209 —
Good Samaritan Hospital Cincinnati Ohio 45220 —
Bethesda North Hospital Cincinnati Ohio 45242 —
Oklahoma Cardiovascular Associates Oklahoma City Oklahoma 73120 —
Oklahoma Cardiovascular Research Group Oklahoma City Oklahoma 73120 —
Oklahoma Heart Hospital Oklahoma City Oklahoma 73120 —
CardioThoracic Surgery Center, PLC Jackson Tennessee 38301 —
Jackson Madison County General Hospital Jackson Tennessee 38301 —
Centennial Medical Center Nashville Tennessee 37203 —
The Methodist Hospital Houston Texas 77030 —
Winchester Medical Center Winchester Virginia 22601 —
FHS Research Center, St. Joseph Medical Center Tacoma Washington 98405 —
Northwest Cardiovascular Associates Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00316212, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2016 · Synced Nov 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00316212 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →